Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131918) titled 'Research on Artificial Intelligence (AI)Assisted System for Longterm Followup and Precision Glucoselowering in Comprehensive Management of Patients with Diabetes and Cardiovascular Diseases' on Sept. 7.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Condition:
Diabetic Cardiovascular Disease
Intervention:
Conventional management group:Glycemic regimen adjusted per routine clinical care
Optimization + Long-term Management Group:Determine glycemic control targets based on cardiovascular risk stratif...